Monica Shaw
Director/Board Member presso AC IMMUNE SA
Patrimonio netto: 27 084 $ in data 31/03/2024
Profilo
Monica Shaw is currently an Independent Non-Executive Director at AC Immune SA, a Senior Vice President-Major Markets at Bristol Myers Squibb Co., and the EVP-Head Region Europe, Canada & Australia at LEO Pharma.
A.
She is also a Member of The Royal College of Physicians and the VP-Commercial & Head-Asia Pacific Region at ViiV Healthcare Co. In the past, she was the Chief Executive Officer at Oncopeptides AB and the Medical Director & Chief Scientific Officer-UK at Novartis AG.
Dr. Shaw received a doctorate degree from Oxford University Medical School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
AC IMMUNE SA
0.01% | 01/03/2024 | 9 150 ( 0.01% ) | 27 084 $ | 31/03/2024 |
Posizioni attive di Monica Shaw
| Società | Posizione | Inizio |
|---|---|---|
| AC IMMUNE SA | Director/Board Member | 29/10/2021 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 06/09/2023 |
| The Royal College of Physicians | Corporate Officer/Principal | - |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - |
| ViiV Healthcare Co. | Corporate Officer/Principal | - |
Precedenti posizioni note di Monica Shaw
| Società | Posizione | Fine |
|---|---|---|
| ONCOPEPTIDES AB | Chief Executive Officer | 07/08/2023 |
| Novartis AG /U.S. Biologics Manufacturing Operation/ | Chief Tech/Sci/R&D Officer | - |
Formazione di Monica Shaw
| Oxford University Medical School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| AC IMMUNE SA | Health Technology |
| ONCOPEPTIDES AB | Health Technology |
| Aziende private | 3 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
| Novartis AG /U.S. Biologics Manufacturing Operation/ | Health Technology |
| ViiV Healthcare Co. |
- Borsa valori
- Insiders
- Monica Shaw
